Neurofibromatosis type 1 gene mutations in neuroblastoma

Nature Genetics

Volumn 3, Issue 1, 1993, Pages 62-66

  The, Inge ^a,b   Murthy, Anita E ^a   Hannigan, Gregory E ^a   Jacoby, Lee B ^a   Menon, Anil G ^a,c   Gusella, James F ^a   Bernards, Andre ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATE; RAS PROTEIN;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROFIBROMATOSIS; NONHUMAN; TUMOR SUPPRESSOR GENE;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMAL; CHROMOSOMES, HUMAN, PAIR 17; GENES, NEUROFIBROMATOSIS 1; GUANOSINE TRIPHOSPHATE; HUMAN; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NEUROBLASTOMA; NEUROFIBROMIN 1; PRECIPITIN TESTS; PROTEINS; PROTO-ONCOGENE PROTEIN P21(RAS); SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0027439597     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0193-62     Document Type: Article

References (34)

1. Riccardi, V.M. Von Recklinghausen neurofibromatosis. New Engl. J. Med.305, 1617-1627 (1981).
2. Barker, D. et al. Gene for von Recklinghausen neurofibromatosis is in the pericentric region of chromosome 17. Science 236, 1100-1102 (1987).
3. Seizinger, B.R. et al. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 49, 589-594 (1987).
4. Viskochil, D. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62, 187-192 (1990).
5. Cawthon, R.M. et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62, 193-201 (1990).
6. Wallace, M.R. et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 240, 181-186 (1990).
7. Xu, G. et al. The neurofibromatosis type-1 gene encodes a protein related to GAP. Cell 62, 599-608 (1990).
8. Buchberg, A.M., Cleveland, L.S., Jenkins, N.A. & Copeland, N.G. Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature 347, 291-294 (1990).
9. De Clue, J.E. et al. Abnormal regulation of mammalian p21^ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69, 265-273 (1992).
10. Basu, T.N. et al. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356, 713-715 (1992).
11. Nishi, T. et al. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene 6, 1555-1559 (1991).
12. Bernards, A. et al. Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line. DNA cell Biol. (in the press).
13. Daston, M.M. et al. The product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 8, 1-14 (1992).
14. Fong, C.T. et al. Loss of heterozygosity for chromosome 1p in human neuroblastomas: correlation with N-myc amplification. Proc. natn. Acad. Sci. U.S.A. 6, 3753-3757 (1989).
15. Gilbert, F. et al. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res. 4, 5444-5449 (1984).
16. Bader, S.A., Fasching, C., Brodeur, G.M. & Stanbridge, E.J. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells.Cell Growth Diff. 2, 245-255 (1991).
17. Bernards, A., Rubin, C.M., Westbrook, C.A., Paskind, M. & Baltimore, D. The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia.Molec. cell. Biol. 7, 3231-3236 (1987).
18. Bernards, A. & de la Monte, S. M. The ltk receptor tyrosine kinase is expressed in pre-B lymphocytes and cerebral neurons and uses a non-AUG translational initiator. EMBO J. 9, 2279-2287 (1990).
19. Furth, M.E., Davis, L.J., Fleurdelys, B & Scolnick, E.M. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J. Virol. 43, 294-304 (1982).
20. Burgering, B.M.T. et al. Insulin stimulation of gene expression mediated by p21^ras activation. EMBO J. 10, 1103-1109 (1991).
21. Trahey, M. & McCormick, F. A cytoplasmic protein stimulates normal N-rasp21 GTPase, but does not affect oncogenic mutants. Science 238, 542-545 (1987).
22. Gibbs, J.B., Schaber, M.D., Allard, W.J., Sigal, I.S. & Scolnick, E.M. Purification of ras GTPase activating protein from bovine brain. Proc. natn. Acad. Sci. U.S.A. 85, 5026-5030 (1988).
23. Taparowski, E., Shimizu, K., Goldfarb, M. & Wigler, M. Structure and activation of the human N-ras gene. Cell 34, 581-586 (1983).
24. Bos, J.L. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689 (1989).
25. Moley, J.F. et al. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.Cancer Res. 51, 1596-1599 (1991).
26. Thomas, S.M., DeMarco, M., D'Arcangelo, G., Halegoua, S. & Brugge, J.S. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68, 1031-1040 (1992).
27. Wood, K.W., Sarnecki, C., Roberts, T.M. & Blenis, J. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68, 1041-1050 (1992).
28. Kushner, B.H., Hajdu, S.I. & Helson, L. Synchronous neuroblastoma and von Recklinghausen's disease: a review of the literature. J. clin. Oncol. 3, 117-120 (1985).
29. Clausen, N., Andersson, P. & Tommerup, N. Familial occurrence of neuroblastoma, von Recklinghausen's neurofibromatosis, Hirschsprung's agangliosis and jaw-winking syndrome. Acta Paediatr. Scand. 78, 736-741 (1989).
30. Li, Y. et al. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69, 275-281 (1992).
31. Shimada, H. et al. Histopathological prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastoma. JNCI 73, 405-416 (1984).
32. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. & Bishop, J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121-1124 (1984).
33. Harlow, E. & Lane, D. Antibodies. A laboratory manual (Cold Spring Harbor Laboratory, New York, 1988).
34. Solomon, E. et al. Human gene mapping using an X/autosome translocation. Som. Cell Genetics 2, 125-140 (1976).